CardioVia

Developer of a minimally invasive device for accessing pericardial space to deliver diagnostic and therapeutic interventions for ventricular tachycardia.

Medical Devices
Active
Tel Aviv, Israel Founded 2017
Last updated 2026-08-06
Total raised
Stage
Founded
2017
Headcount
8
HQ
Tel Aviv, Israel
Sector
Medical Devices

About

CardioVia is an innovative medical device company specializing in advanced cardiac care solutions. The company has developed ViaOne™, an FDA-cleared epicardial access device designed to create a stable, precise pathway to the heart's surface (pericardial space) without an exposed needle, reducing the risk of heart perforation. ViaOne™ enables minimally invasive access for a wide range of cardiac conditions, including arrhythmia treatments, advanced therapies like stem cell and gene delivery, and interventions for myocardial infarction and heart failure.

Headcount over time

8 employees (2026-09) · 1 point
8 8 2026-09

Offices

Tel Aviv, Israel · HQ / main office

Q&A

What is CardioVia's primary focus?
CardioVia is a medical device company that develops ViaOne™, an FDA-cleared epicardial access device designed to create a stable, precise pathway to the heart's surface (pericardial space) for various cardiac conditions.
When was CardioVia founded?
CardioVia was founded in 2017.
Who are the co-founders of CardioVia?
The co-founders of CardioVia include Ziv Menshes (CEO), Yonatan Demma, Or Hazan (COO), Dr. Ran Eliaz, and Dr. Yonatan Avraham Demma.
How many employees does CardioVia currently have?
As of August 2026, CardioVia has 8 employees.
What is CardioVia's total funding to date?
CardioVia has raised a total of $836,000 USD.
Which investors participated in CardioVia's Grant round in May 2019?
The Grant round in May 2019 included Europa and Yissum.
What is the main technology behind CardioVia's device?
CardioVia's core technology includes a blunt-tip concealed needle and a bio-impedance navigation system for safe pericardial access.
What is the status of CardioVia's device, ViaOne™?
ViaOne™ is an FDA-cleared epicardial access device.

Team · 8

Ziv Menshes
Founder · CEO & Co-founder
Yonatan Demma
Founder · Co-Founder
Or Hazan
Founder · COO & Co-Founder
Dr. Ran Eliaz
Founder · Medical Advisor & Co-Founder
Dr. Yonatan Avraham Demma
Founder · Medical Advisor & Co-Founder
Prof. David Luria
Medical Director
Dr. Susan Alpert
Regulatory Affairs
Nizar Mishael
CFO

Sectors & technology

Primary sector
Medical Devices
Technologies
Target customers
Business model
B2B
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitewww.cardiovia.com

Identifiers & details

Legal nameCardioVia
Founded2017
Employees (exact)8

Radar intelligence

Patents

EPO1

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)515825149
Statusפעילה
Corp typeישראלית חברה פרטית
Incorporated2018-04-08
Purposeלעסוק בכל עיסוק חוקי
Liabilityמוגבלת
In violation (unfiled)no
Last annual report2024
Active charges / liens0
Registry events2 — people (2)
Registered addressואדי אל-חאג' 13 נצרת

Recent registry events

DateEvent
2026-07-23עדכון דירקטורים-הוספת דירקטור
2026-07-23עדכון דירקטורים-הסרת דירקטור